Community Shares | July 15th 2024
This week’s articles: The recent U.S. Supreme Court ruling in Loper Bright Enterprises v. Raimondo, which overturned the 1984 Chevron precedent, may significantly impact the rights of people with disabilities; New research has highlighted the potential of using a combination of biomarkers to improve the diagnosis and understanding of ASD; A brief research report article has highlighted the connection between maternal autoantibodies (MAR-ABs) and increased inflammation during pregnancy, which may contribute to a higher risk of autism in their children;A recent study has identified brain energy metabolism dysfunction, marked by altered pH and lactate levels, as a common trait in various animal models of neuropsychiatric and neurodegenerative disorders, including autism spectrum disorders (ASD), schizophrenia, bipolar disorder, depression, and Alzheimer’s disease.
Autoantibodies and Autism, Is There a Connection?
Although there are still no definitive answers for what causes autism spectrum disorder (ASD), there is a good deal of research that points to an interaction between genetics and environmental factors as a possible mechanism for causation. Over the past two decades, associations between immune system abnormalities and autism have been linked. A new systematic review from Harvard Medical School, among other institutions, examines this intricate relationship.
